2.43 USD
↗ 0.07 (2.97%)AT CLOSE (11:59 AM EDT)
INmune Bio Inc. Common stock (INMB) trades at $2.35 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place INMB at a fair price relative to peers.
Technical & fundamental data as of Aug 25, 2026.